BRPI0401742B8 - composto análogo do ritonavir útil como inibidor de protease retroviral, preparação do composto análogo do ritonavir e composição farmacêutica do composto análogo do ritonavir - Google Patents
composto análogo do ritonavir útil como inibidor de protease retroviral, preparação do composto análogo do ritonavir e composição farmacêutica do composto análogo do ritonavirInfo
- Publication number
- BRPI0401742B8 BRPI0401742B8 BRPI0401742A BRPI0401742A BRPI0401742B8 BR PI0401742 B8 BRPI0401742 B8 BR PI0401742B8 BR PI0401742 A BRPI0401742 A BR PI0401742A BR PI0401742 A BRPI0401742 A BR PI0401742A BR PI0401742 B8 BRPI0401742 B8 BR PI0401742B8
- Authority
- BR
- Brazil
- Prior art keywords
- ritonavir
- analogue compound
- pharmaceutical composition
- protease inhibitor
- analogue
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D277/28—Radicals substituted by nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D277/24—Radicals substituted by oxygen atoms
Abstract
composto análogo do ritonavir útil como inibidor de protease retroviral, preparação do composto análogo do ritonavir e composição farmacêutica do composto análogo do ritonavir a presente invenção descreve a síntese de um novo composto análogo do ritonavir que apresenta atividade significativamente superior ao ritonavir na inibição da protease do hiv. são também descritos o uso do composto análogo do ritonavir da presente invenção, ou seu sal, éster ou pro-droga, como ingrediente ativo em composições farmacêuticas bem como o uso do composto e das composições farmacêuticas em medicina, particularmente no tratamento de infecção por hiv, sozinho ou em combinação com outros medicamentos anti-hiv.
Priority Applications (10)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BRPI0401742A BRPI0401742B8 (pt) | 2004-05-13 | 2004-05-13 | composto análogo do ritonavir útil como inibidor de protease retroviral, preparação do composto análogo do ritonavir e composição farmacêutica do composto análogo do ritonavir |
PCT/BR2005/000077 WO2005111006A1 (en) | 2004-05-13 | 2005-05-11 | Ritonavir analogous compound useful as retroviral protease inhibitor, preparation of the ritonavir analogous compound and pharmaceutical composition for the ritonavir analogous compound. |
MXPA06013188A MXPA06013188A (es) | 2004-05-13 | 2005-05-11 | Compuesto analogo de ritonavir util como inhibidor de proteasa retroviral, preparacion del compuesto analogo de ritonavir y composicion farmaceutica para el compuesto analogo de ritonavir. |
JP2007511791A JP4993747B2 (ja) | 2004-05-13 | 2005-05-11 | レトロウイルスプロテアーゼ阻害剤として有用なリトナビル類似化合物、そのリトナビル類似化合物の製造方法及びそのリトナビル類似化合物の薬学的組成物 |
AT05738457T ATE480526T1 (de) | 2004-05-13 | 2005-05-11 | Als inhibitor von retroviraler protease geeignete ritonavir-analoge verbindung, herstellung der ritonavir-analogen verbindung und pharmazeutische zusammenetzung für die ritonavir-analoge verbindung |
US11/596,469 US7763733B2 (en) | 2004-05-13 | 2005-05-11 | Ritonavir analogous compound useful as retroviral protease inhibitor, preparation of the ritonavir analogous compound and pharmaceutical composition for the ritonavir analogous compound |
DE602005023437T DE602005023437D1 (de) | 2004-05-13 | 2005-05-11 | Als inhibitor von retroviraler protease geeignete ritonavir-analoge verbindung, herstellung der ritonavir-analogen verbindung und pharmazeutische zusammenetzung für die ritonavir-analoge verbindung |
EP05738457A EP1751125B1 (en) | 2004-05-13 | 2005-05-11 | Ritonavir analogous compound useful as retroviral protease inhibitor, preparation of the ritonavir analogous compound and pharmaceutical composition for the ritonavir analogous compound. |
CN200580021778A CN100584833C (zh) | 2004-05-13 | 2005-05-11 | 可用作逆转录病毒蛋白酶抑制剂的利托那韦类似化合物、利托那韦类似化合物的制备和利托那韦类似化合物的药物组合物 |
HK07113471.4A HK1107699A1 (en) | 2004-05-13 | 2007-12-11 | Ritonavir analogous compound useful as retroviral protease inhibitor, preparation of the ritonavir analogous compound and pharmaceutical composition for the ritonavir analogous compound |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BRPI0401742A BRPI0401742B8 (pt) | 2004-05-13 | 2004-05-13 | composto análogo do ritonavir útil como inibidor de protease retroviral, preparação do composto análogo do ritonavir e composição farmacêutica do composto análogo do ritonavir |
Publications (3)
Publication Number | Publication Date |
---|---|
BRPI0401742A BRPI0401742A (pt) | 2006-01-10 |
BRPI0401742B1 BRPI0401742B1 (pt) | 2019-04-16 |
BRPI0401742B8 true BRPI0401742B8 (pt) | 2021-05-25 |
Family
ID=36072150
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0401742A BRPI0401742B8 (pt) | 2004-05-13 | 2004-05-13 | composto análogo do ritonavir útil como inibidor de protease retroviral, preparação do composto análogo do ritonavir e composição farmacêutica do composto análogo do ritonavir |
Country Status (10)
Country | Link |
---|---|
US (1) | US7763733B2 (pt) |
EP (1) | EP1751125B1 (pt) |
JP (1) | JP4993747B2 (pt) |
CN (1) | CN100584833C (pt) |
AT (1) | ATE480526T1 (pt) |
BR (1) | BRPI0401742B8 (pt) |
DE (1) | DE602005023437D1 (pt) |
HK (1) | HK1107699A1 (pt) |
MX (1) | MXPA06013188A (pt) |
WO (1) | WO2005111006A1 (pt) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RS54237B9 (sr) | 2006-07-07 | 2019-07-31 | Gilead Sciences Inc | Modulatori farmakokinetičkih svojstava terapeutika |
EP2465856A3 (en) * | 2006-08-31 | 2012-12-12 | Abbott Laboratories | Cytochrome P450 oxidase inhibitors and uses thereof |
PL3150586T3 (pl) | 2007-02-23 | 2020-06-01 | Gilead Sciences, Inc. | Modulatory farmakokinetycznych właściwości środków terapeutycznych |
AU2008275744A1 (en) | 2007-07-06 | 2009-01-15 | Gilead Sciences, Inc. | Modulators of pharmacokinetic properties of therapeutics |
CN102786494B (zh) * | 2012-07-26 | 2016-01-06 | 合肥华方医药科技有限公司 | 利托那韦异构体杂质的合成研究及控制方法 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5354866A (en) * | 1989-05-23 | 1994-10-11 | Abbott Laboratories | Retroviral protease inhibiting compounds |
US5539122A (en) * | 1989-05-23 | 1996-07-23 | Abbott Laboratories | Retroviral protease inhibiting compounds |
IE913840A1 (en) * | 1990-11-20 | 1992-05-20 | Abbott Lab | Retroviral protease inhibiting compounds |
US5567823A (en) * | 1995-06-06 | 1996-10-22 | Abbott Laboratories | Process for the preparation of an HIV protease inhibiting compound |
US5914332A (en) | 1995-12-13 | 1999-06-22 | Abbott Laboratories | Retroviral protease inhibiting compounds |
ZA9710071B (en) | 1996-11-21 | 1998-05-25 | Abbott Lab | Pharmaceutical composition. |
MY145265A (en) | 1998-07-20 | 2012-01-13 | Abbott Lab | Amorphous ritonavir |
-
2004
- 2004-05-13 BR BRPI0401742A patent/BRPI0401742B8/pt active IP Right Grant
-
2005
- 2005-05-11 DE DE602005023437T patent/DE602005023437D1/de active Active
- 2005-05-11 EP EP05738457A patent/EP1751125B1/en active Active
- 2005-05-11 US US11/596,469 patent/US7763733B2/en not_active Expired - Fee Related
- 2005-05-11 AT AT05738457T patent/ATE480526T1/de not_active IP Right Cessation
- 2005-05-11 MX MXPA06013188A patent/MXPA06013188A/es active IP Right Grant
- 2005-05-11 JP JP2007511791A patent/JP4993747B2/ja not_active Expired - Fee Related
- 2005-05-11 CN CN200580021778A patent/CN100584833C/zh not_active Expired - Fee Related
- 2005-05-11 WO PCT/BR2005/000077 patent/WO2005111006A1/en active Application Filing
-
2007
- 2007-12-11 HK HK07113471.4A patent/HK1107699A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EP1751125B1 (en) | 2010-09-08 |
BRPI0401742A (pt) | 2006-01-10 |
BRPI0401742B1 (pt) | 2019-04-16 |
US20070244168A1 (en) | 2007-10-18 |
ATE480526T1 (de) | 2010-09-15 |
CN100584833C (zh) | 2010-01-27 |
US7763733B2 (en) | 2010-07-27 |
MXPA06013188A (es) | 2007-02-14 |
JP4993747B2 (ja) | 2012-08-08 |
CN1980907A (zh) | 2007-06-13 |
JP2007537166A (ja) | 2007-12-20 |
DE602005023437D1 (de) | 2010-10-21 |
WO2005111006A1 (en) | 2005-11-24 |
HK1107699A1 (en) | 2008-04-11 |
EP1751125A1 (en) | 2007-02-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0312573A (pt) | Derivados de fenil-[4-(3-fenil-1h-pirazol-4-il)-pirimidin-2-il]-amina | |
EA200401436A1 (ru) | Ингибиторы протеазы вич для лечения инфекции вич и фармацевтическая композиция | |
DE60336664D1 (de) | Nichtnukleosidische reverse-transkriptase-hemmer | |
WO2006096439A3 (en) | Pharmaceutical compositions for the treatment and/or prevention of schizophrenia and related diseases | |
TW200722081A (en) | New therapeutic combinations for the treatment or prevention of depression | |
CU23794B7 (es) | Inhibidores macrocíclicos de la replicación del virus de la hepatitis c | |
BRPI0508579A (pt) | composto, composição farmacêutica, e, uso de um composto | |
EA200702242A1 (ru) | Использование сульфонамидного соединения для улучшения фармакокинетики лекарственного средства | |
PH12014501334A1 (en) | Fluoromethyl-5,6-dihydro-4h-[1,3]oxazines | |
EA202191286A1 (ru) | Ингибитор 15-pgdh | |
BRPI0512970A (pt) | prodrogas de inibidores da hiv protease | |
CY1109440T1 (el) | Φωσφοϊνδολες ως αναστολεις hiv | |
MA32841B1 (fr) | Composés de cycloundeca depsipeptides et leur utilisation comme médicament | |
BRPI0513051A (pt) | combinação de inibidores de transcriptase reversa e de protease anti-hiv | |
WO2006108682A3 (en) | Substances and pharmaceutical compositions for the inhibition of glyoxalases and their use as anti-fungal agents | |
HK1107699A1 (en) | Ritonavir analogous compound useful as retroviral protease inhibitor, preparation of the ritonavir analogous compound and pharmaceutical composition for the ritonavir analogous compound | |
DOP2006000024A (es) | Tiazolidinonas, su preparación y su uso como medicamento | |
EA200702336A1 (ru) | ПРИМЕНЕНИЕ 24-норУДХК | |
NI200700176A (es) | Compuestos peptídicos | |
ECSP045405A (es) | Penems 6-alquiliden heterotriciclil como inhibidores de la beta lactamasa | |
DE602006012962D1 (de) | Pharmazeutische Zubereitungen von Ciprofloxacin | |
ATE496899T1 (de) | Tetrahydro- und dihydrochinazolinone | |
BRPI0507985A (pt) | derivados de piperazina uréia para o tratamento de endometriose | |
UY27628A1 (es) | "2'-halo -3',5'-dialcoxi-fen-1'il-2-imidazolidinas y su uso como un fármaco" | |
SE0203817D0 (sv) | New composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B03A | Publication of a patent application or of a certificate of addition of invention [chapter 3.1 patent gazette] | ||
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B15K | Others concerning applications: alteration of classification |
Free format text: PARA INT.CL: C07D 277/24, A61K 31/426, A61P 31/00 Ipc: C07D 277/24 (2011.01), A61K 31/426 (2011.01) |
|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 16/04/2019, OBSERVADAS AS CONDICOES LEGAIS. (CO) 10 (DEZ) ANOS CONTADOS A PARTIR DE 16/04/2019, OBSERVADAS AS CONDICOES LEGAIS |
|
B16C | Correction of notification of the grant [chapter 16.3 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 13/05/2004 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF |